Grant McArthur
Peter MacCallum Cancer Centre, VIC, Australia
- This delegate is presenting an abstract at this event.
Grant McArthur, Australia
Professor Grant McArthur is co-head of the Cancer Therapeutics Program and Translational Research Laboratory at the Peter MacCallum Cancer Centre in Melbourne, Australia. He is Director of the Skin and Melanoma Clinical Service, a Fellow of the Royal Australasian College of Physicians and holds a PhD in Medical Biology. Professor McArthur is a previous recipient of the Translational Research Award of the Fondation Nelia et Amadeo Barletta and the Sir Edward Dunlop Clinical Cancer Research Fellowship of the Cancer Council of Victoria. He was recently appointed as the inaugural Lorenzo and Pamela Galli Chair of Melanoma and Skin Cancers at the University of Melbourne and is national and international study co-chair of a number of clinical trials for targeted therapies.
Professor McArthur currently sits on the editorial boards of a number of Journals including the Journal of Clinical Oncology, Annals of Oncology and Anti-Cancer Drugs. His research interests include clinical trials of targeted therapeutics, molecular profiling of cancer, melanoma, cell cycle control, differentiation, oncogene addiction, gastrointestinal stromal tumour, and functional imaging. Recent work has focused on oncogene addiction driven by MYC, KIT, RAS and BRAF in a variety of malignant conditions to develop an understanding of the basic cellular mechanisms of cancer that can assist in the development and application of novel targeted cancer therapeutics. To date, Professor McArthur has published over 150 papers in peer-reviewed journals.
Presentations this author is a contributor to:
Overcoming resistance to therapies targeting oncogenes (#21)
1:00 PM
Grant McArthur
Symposium 7: Personalised medicine in the clinic
Functional genomics of BRAF-driven glycolysis in BRAFV600 melanoma (#148)
2:15 PM
Lorey Smith
Afternoon Tea/Poster Session
Disabled negative feedback regulation by SPROUTY2 sustains EGFR, FGFR and c-MET mediated resistance to BRAF inhibitor treatment in melanoma (#130)
2:15 PM
Frederic Li
Afternoon Tea/Poster Session